Home › Companies › Aurinia Pharmaceuticals Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Aurinia Pharmaceuticals Inc.’s Form 8-K, filed June 4, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 3, 2026: 7 items on Aurinia Pharmaceuticals Inc.’s Form 8-K, filed June 4, 2026: 2 approved · 5 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Aurinia Pharmaceuticals Inc. in the interactive database Compare manager voting policies
These tallies are Aurinia Pharmaceuticals Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Kevin Tang | 68,889,411 | -- | -- | 2,434,090 | 16,049,984 | 97% | Not verified | — |
| Elect Director: Jeffrey Bailey | 67,990,723 | -- | -- | 3,332,778 | 16,049,984 | 95% | Not verified | — |
| Elect Director: Kathy Goetz | 68,840,807 | -- | -- | 2,482,694 | 16,049,984 | 97% | Not verified | — |
| Elect Director: Craig Johnson | 61,694,786 | -- | -- | 9,628,715 | 16,049,984 | 86% | Not verified | — |
| Elect Director: Tina S. Nova | 61,972,942 | -- | -- | 9,350,560 | 16,049,983 | 87% | Not verified | — |
| Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm until the annual general meeting of shar | 77,785,132 | -- | -- | 9,488,350 | 3 | 89% | Approved | — |
| Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation. | 66,398,971 | 4,315,143 | 609,384 | -- | 16,049,987 | 94% | Approved | — |
Source: Aurinia Pharmaceuticals Inc., Form 8-K, filed with the SEC on June 4, 2026 — read the filing on EDGAR.
Each item below shows how the 259 asset managers that disclosed a Aurinia Pharmaceuticals Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Aurinia Pharmaceuticals Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 3 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kevin Tang
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kevin Tang”): 68,889,411 for, 2,434,090 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Aurinia Pharmaceuticals Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “To elect the following five director nominees presented by the Board: Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova, Ph.D. Jeffrey Bailey” (9 managers, 4,896,599 for); “To elect the following five director nominees presented by the Board: Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova, Ph.D. Kathy Goetz” (9 managers, 4,896,599 for); “To elect the following five director nominees presented by the Board: Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova, Ph.D. Kevin Tang” (9 managers, 4,896,599 for); “To elect the following five director nominees presented by the Board: Kevin Tang, Jeffrey Bailey, Kathy Goetz, Craig Johnson and Tina S. Nova, Ph.D. Tina S. Nova, Ph.D.” (9 managers, 4,896,599 for).
The 63 asset managers below reported 12,674,559 for, 19,562 withheld, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,262,886 | 0 | 3 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 0 | 9,833 | Mixed |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Combines 2 wordings of this item as funds reported it.
86% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Craig Johnson
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Craig Johnson”): 61,694,786 for, 9,628,715 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 86% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 7,786,782 for, 10,732 withheld, 12 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,261,979 | 0 | 12 | 899 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 0 | 9,833 | Mixed |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 2 wordings of this item as funds reported it.
95% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Jeffrey A. Bailey
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Jeffrey Bailey”): 67,990,723 for, 3,332,778 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 95% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 7,777,061 for, 20,461 withheld, 4 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,261,987 | 0 | 4 | 899 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 0 | 9,833 | Mixed |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 2 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Kathy Goetz
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Kathy Goetz”): 68,840,807 for, 2,482,694 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 7,777,960 for, 19,562 withheld, 3 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,262,886 | 0 | 3 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 0 | 9,833 | Mixed |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 2 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Tina S. Nova
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Elect Director: Tina S. Nova”): 61,972,942 for, 9,350,560 withheld, per its Form 8-K filed June 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 87% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 54 asset managers below reported 7,777,951 for, 19,562 withheld, 12 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,262,877 | 0 | 12 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 140,000 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 0 | 9,833 | Mixed |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Showing the 25 largest of 54 asset managers. See all 54 in the interactive database.
Combines 5 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the Company's executive compensation set forth in the Company's Proxy Statement/Circular.
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”): 66,398,971 for, 4,315,143 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of Aurinia Pharmaceuticals Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (8 managers, 109,699 for, 308,247 against); “APPROVAL OF COMPENSATION OF EXECUTIVE OFFICERS” (4 managers, 12,467,145 for); “To approve on a non-binding advisory basis the Companys executive compensation set forth in the Companys Proxy Statement/Circular” (2 managers, 2,803 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,262,883 | 5 | 1 | 0 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 0 | 100,545 | 0 | 0 | Against |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 0 | 0 | 83,000 | 0 | Abstain |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 9,833 | 0 | Mixed |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
| Global X | 56,493 | 0 | 0 | 0 | For |
| Nationwide | 56,482 | 0 | 0 | 0 | For |
| PACE SELECT ADVISORS TRUST | 54,962 | 0 | 0 | 0 | For |
Fund voting reports, all 53 managers: 7,546,497 for, 100,669 against, 92,834 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 3,969,834 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 2,408,157 | 0 | 0 | 0 | For |
| Two Sigma | 1,822,991 | 0 | 0 | 0 | For |
| State Street | 1,725,301 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,541,858 | 0 | 0 | 0 | For |
| Janus Henderson | 1,428,424 | 0 | 0 | 0 | For |
| Renaissance | 850,227 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 831,547 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 803,419 | 0 | 0 | 0 | For |
| DE Shaw | 713,789 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 691,472 | 0 | 0 | 0 | For |
| Nuveen | 636,948 | 0 | 0 | 0 | For |
| Prudential/PGIM | 583,910 | 0 | 0 | 0 | For |
| Goldman Sachs | 561,816 | 0 | 0 | 0 | For |
| AQR | 479,322 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 364,378 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 350,794 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 350,562 | 0 | 0 | Against |
| Fidelity | 347,929 | 0 | 0 | 0 | For |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 275,300 | 0 | 0 | 0 | For |
| Vanguard | 233,775 | 0 | 0 | 0 | For |
| ClariVest Asset Management LLC | 213,942 | 0 | 0 | 0 | For |
| Hillsdale Investment Management Inc. | 209,900 | 0 | 0 | 0 | For |
| UBS | 0 | 204,194 | 0 | 0 | Against |
Institutional-manager reports, all 146 managers: 24,664,735 for, 920,942 against, 7,001 not voted. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
94% Approved · of votes cast
Description as filed by funds: To approve on a non-binding advisory basis the Company's executive compensation set forth in this Proxy Statement/Circular (the "say-on-pay" vote).
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”): 66,398,971 for, 4,315,143 against — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Based upon the following votes, the shareholders approved, on a non-binding advisory basis, a "say on pay" resolution regarding the Corporation's executive compensation.”
Support: 94% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| John Hancock | 30,865 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,949 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 12,711 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST II | 4,223 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 3,264 | 0 | 0 | 0 | For |
Fund voting reports, all 8 managers: 4,896,599 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 2,504,472 | 2,870 | 0 | 0 | For |
| Northern Trust | 693,696 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 608,318 | 0 | 0 | 0 | For |
| Goldman Sachs | 322,986 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 244,292 | 0 | 0 | 0 | For |
| PNC BANK, NATIONAL ASSOCIATION | 236,688 | 0 | 0 | 0 | For |
| WELLS FARGO ADVISORS FINANCIAL NETWORK, LLC | 234,639 | 0 | 0 | 0 | For |
| ROCKEFELLER FINANCIAL LLC | 81,244 | 0 | 0 | 0 | For |
| Capital Investment Advisors, LLC | 33,750 | 0 | 0 | 0 | For |
| Acropolis Investment Management, LLC | 19,657 | 0 | 0 | 0 | For |
| Corient Private Wealth LP | 12,622 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 11,367 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 10,085 | 0 | 0 | 0 | For |
| GRIMES & Co WEALTH MANAGEMENT, LLC | 9,830 | 0 | 0 | 0 | For |
| US BANK NATIONAL ASSOCIATION | 8,820 | 0 | 0 | 0 | For |
| OPPENHEIMER & CO INC | 8,420 | 0 | 0 | 0 | For |
| First Bank & Trust | 6,536 | 0 | 0 | 0 | For |
| Focus Partners Wealth | 6,000 | 0 | 0 | 0 | For |
| Cerity Partners LLC | 3,452 | 0 | 0 | 0 | For |
| SCOTIA CAPITAL INC. | 2,606 | 0 | 0 | 0 | For |
| Soltis Investment Advisors LLC | 2,500 | 0 | 0 | 0 | For |
| Savant Capital, LLC | 2,001 | 0 | 0 | 0 | For |
| D.A. DAVIDSON & CO. | 2,000 | 0 | 0 | 0 | For |
| SALEM INVESTMENT COUNSELORS INC | 1,900 | 0 | 0 | 0 | For |
| WELLS FARGO CLEARING SERVICES, LLC | 1,603 | 0 | 0 | 0 | For |
Institutional-manager reports, all 56 managers: 5,086,392 for, 2,870 against. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
89% Approved · of votes cast
Description as filed by funds: Appointment of Auditors To approve the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company's independent registered public accounting firm until the close of the 2027 annual general meeting of shareholders or until a successor is appointed.
Aurinia Pharmaceuticals Inc.’s own tally for this item (“Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm ”): 77,785,132 for, 9,488,350 withheld — passed, per its Form 8-K filed June 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Based upon the following votes, the shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Corporation's independent registered public accounting firm until the annual general meeting of shareholders to be held in 2027 or until a …”
Support: 89% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 63 asset managers below reported 12,626,381 for, 10,732 withheld, 12 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 4,531,155 | 0 | 0 | 0 | For |
| Fidelity | 1,775,814 | 0 | 0 | 0 | For |
| Vanguard | 1,261,979 | 0 | 12 | 899 | For |
| Janus Detroit Street Trust | 701,485 | 0 | 0 | 0 | For |
| TIAA | 613,715 | 0 | 0 | 0 | For |
| Charles Schwab | 454,130 | 0 | 0 | 0 | For |
| American Century | 361,131 | 0 | 0 | 0 | For |
| State Street | 277,507 | 0 | 0 | 0 | For |
| Equitable | 255,018 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 199,220 | 0 | 0 | 0 | For |
| JPMorgan | 185,399 | 0 | 0 | 0 | For |
| Goldman Sachs | 159,431 | 0 | 0 | 0 | For |
| Lincoln Financial | 155,910 | 0 | 0 | 0 | For |
| Principal Exchange-Traded Funds | 116,180 | 0 | 0 | 0 | For |
| Invesco | 100,545 | 0 | 0 | 0 | For |
| DIAMOND HILL FUNDS | 92,212 | 0 | 0 | 0 | For |
| Prudential/PGIM | 89,600 | 0 | 0 | 0 | For |
| DWS | 85,026 | 0 | 0 | 0 | For |
| HUSSMAN INVESTMENT TRUST | 83,000 | 0 | 0 | 0 | For |
| Northern Trust | 78,901 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 73,909 | 0 | 0 | 0 | For |
| Federated Hermes | 66,338 | 0 | 0 | 0 | For |
| Brighthouse | 53,531 | 0 | 0 | 9,833 | Mixed |
| TARGET PORTFOLIO TRUST | 62,000 | 0 | 0 | 0 | For |
| ETFis Series Trust I | 57,386 | 0 | 0 | 0 | For |
Showing the 25 largest of 63 asset managers. See all 63 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 130,771,000 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 3.46% |
| 2 | Fidelity | 1.36% |
| 3 | Vanguard | 0.97% |
| 4 | Janus Detroit Street Trust | 0.54% |
| 5 | TIAA | 0.47% |
| 6 | Charles Schwab | 0.35% |
| 7 | American Century | 0.28% |
| 8 | State Street | 0.21% |
| 9 | Equitable | 0.20% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.15% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | NEA Management Company, LLC | 3.04% |
| 2 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.84% |
| 3 | Two Sigma | 1.39% |
| 4 | State Street | 1.32% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 1.18% |
| 6 | Janus Henderson | 1.09% |
| 7 | Renaissance | 0.65% |
| 8 | LSV ASSET MANAGEMENT | 0.64% |
| 9 | JUPITER ASSET MANAGEMENT LTD | 0.61% |
| 10 | DE Shaw | 0.55% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| BlackRock | 6.00% | 13F |
| Chin Kyu Huh | 4.52% | 13D |
| Two Sigma | 2.62% | 13F |
| State Street | 1.93% | 13F |
| Morgan Stanley | 1.70% | 13F |
| Renaissance Technologies | 1.27% | 13F |
| D.E. Shaw | 1.20% | 13F |
| Geode Capital | 1.17% | 13F |
| Vanguard Group | 1.11% | 13F |
| Goldman Sachs | 1.10% | 13F |
Percentages above are of 130,771,000 shares outstanding, as reported by Aurinia Pharmaceuticals Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Aurinia Pharmaceuticals Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At Aurinia Pharmaceuticals Inc.'s shareholder meeting held June 3, 2026, in the 2025-2026 proxy season, 259 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,478 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Advisory Resolution on Executive Compensation To approve, on a non-binding advisory basis, the… — Aurinia Pharmaceuticals Inc.'s filing reports the proposal as approved, with 94% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Aurinia Pharmaceuticals Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 4, 2026.
Aurinia Pharmaceuticals Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.